Literature DB >> 19120923

Microbiological challenge of four protective devices for the reconstitution of cytotoxic agents.

K De Prijck1, E D'Haese, J Vandenbroucke, W Coucke, H Robays, H J Nelis.   

Abstract

AIMS: To evaluate the susceptibility to microbial contamination that occurs during simulated handling of protective devices for the preparation of cytotoxic drug solutions. METHODS AND
RESULTS: Four devices, i.e. Chemoprotect spike, Clave connector, PhaSeal and Securmix were challenged with low and high inocula of micro-organisms. The cells, transferred to the connected vials during repeated manipulations of the devices were counted by means of solid-phase cytometry. Of the four devices, PhaSeal afforded the lowest transfer of micro-organisms. Secondly, the efficiency of procedures for the disinfection of an artificially contaminated rubber stopper was compared prior to connection of the vial to the PhaSeal device. Spraying or swabbing alone was inadequate, as opposed to a combination of spraying [0.5% or 2.0% (w/v) chlorhexidine in isopropanol] and swabbing [70% (v/v) isopropanol].
CONCLUSIONS: Although Phaseal afforded the lowest transfer of micro-organisms, adequate disinfection of the vial prior to connection remains required. SIGNIFICANCE AND IMPACT OF THE STUDY: Unlike aspects of operator protection, which are well documented, the microbiological safety of protective devices for the preparation of cytotoxic drugs has not been addressed in the literature. This study estimates the susceptibility to microbial contamination during handling of four commonly used devices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120923     DOI: 10.1111/j.1472-765X.2008.02463.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  7 in total

1.  Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs.

Authors:  Erinn C Rowe; Scott W Savage; William A Rutala; David J Weber; Maria Gergen-Teague; Stephen F Eckel
Journal:  J Oncol Pract       Date:  2012-06-12       Impact factor: 3.840

2.  Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs.

Authors:  Annaelle Soubieux; Cynthia Tanguay; Jean Lachaine; Jean-François Bussières
Journal:  Eur J Hosp Pharm       Date:  2019-02-22

3.  Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation.

Authors:  Lucrezia Ferrario; Fabrizio Schettini; Elisabetta Garagiola; Adriana Cecchi; Lucia Lugoboni; Paolo Serra; Emanuele Porazzi; Emanuela Foglia
Journal:  Clinicoecon Outcomes Res       Date:  2020-12-01

Review 4.  Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices.

Authors:  Annaelle Soubieux; Cynthia Tanguay; Jean-François Bussières
Journal:  Eur J Hosp Pharm       Date:  2019-05-15

5.  Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital

Authors:  Huan Keat Chan; Yik Ming Lim
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

6.  Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners.

Authors:  Manmeet Khaira; Allison L Guy
Journal:  J Oncol Pharm Pract       Date:  2021-05-18       Impact factor: 1.416

Review 7.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.